5 funding opportunities are listed in this category
Grant for Advanced Training Elective in Consultative Hematopathology and Solid Tumors
Available Funding: A maximum of $5,000 for the four week training rotation will be provided for each location, New York, Los Angeles, and Milan. Funding is available for up to 2 residents. Any expenses exceeding this amount are the responsibilities of the resident awardee.About the Grant: This grant opportunity is for pathology residents and fellows in training who seek to gain advanced diagnostic experience in hematologic and solid tumor malignancies. Residents will have the opportunity to work in one of two state of the art laboratories located in Manhattan, New York or Los Angeles, California. There is only one laboratory in Milan, Italy and residents will work under the overall direction of Michael Dugan, MD, FCAP.Location supervisors for New York will be Bruce Horten, MD, FCAP, and Henry Dong, MD, FCAP. Supervisors for Los Angeles will be Moacyr DaSilva, MD, FCAP, and Jess Savala, MD. The Milan, Italy supervisor will be Juan Rosai, MD, FCAP.Expected Accomplishments for Residents: 1. Obtain hands-on experience with high volume, challenging hematologic and solid tumor diagnostic consultations. The training in Milan will be focused on diagnostic consultation, primarily solid tumor, with accompanying IHC under the direction of Dr. Juan Rosai. 2. Receive detailed instruction and hands-on experience (in NY or LA only) with 1. Flow cytometry 2. Molecular technologies 3. Cytogenetics 4. Fluorescence in situ hybridization (FISH) 5. Immunohisochemistry (IHC)3. Participate in review of diagnostic consultations regarding rare or unusual tumors. 4. In Milan, the awardee will receive detailed exposure to rare cases forwarded to Dr. Rosai from around the world. This would be about 50% thyroid/mediastinal tumors and about 50% other cases. The case mix would be about 50% from U.S. and 50% from other countries. The fellow would receive experience in Immunohistochemistry (IHC) interpretation related to this cases and help prepare the reports generated by Dr. Rosai.Eligibility Requirements: * Applicant must be a Junior Member of CAP or have an application in process * Applicant must have at least one year of AP training including at least six months of applicable surgical pathology training, and at least 2 months of hematopathology related training. * Additional experience in hematopathology or genetics preferred.Selection Criteria:Application will be judged on the following: * Merit of application and narrative * Education value to the applicant * Applicant background and current knowledge of pathology practice * Program director’s recommendationReporting Requirements * After completion of rotation, the grant recipient(s) must submit a report and evaluation of the experience to CAP Foundation which will be shared with Genzyme Genetics.* The CAP Foundation may communicate the results of the completed project to CAP resource committees and Genzyme Genetics Medical Directors who are best positioned to use them. Copies of any communications sent will be mailed to the award recipient. * Recipients are to submit a photo(s) and share their experience in writing with others. * The grant recipient(s) may submit an abstract of his/her research experience or project to the CAP and/or other pathology related annual meetings.
Application Guidelines: (all material must be typed)Deadline: October 1 1. Completed Application Form 2. A current curriculum vita 3. A letter of recommendation from the director of the applicant’s residency program indicating that salary and benefits will be supported during the award period 4. A narrative, not to exceed two pages, describing the: 1. Applicant’s interest in fellowship training area, why this experience is desired, and how it will enhance their training in pathology 2. Description of any previous experience that will be helpful to fulfill the elective objectives 3. Benefit to society and the practice of pathology that this experience will provide 4. Why the Foundation support is needed and what other means of support are availableNOTE: Applicants must select a first and second choice for training locations from Manhattan, Los Angeles, or Milan. If selecting Milan, Italy, candidates must hold a valid U.S. passport and be eligible for a non-working visitor’s visa.Candidates must be prepared to pay all expenses for their stay in NY, LA or Milan which exceed the amount provided by this grant. This typically might include food, ancillary travel or entertainment expenses, or could including housing expenses that exceed the amount provided by CAP fellowship award.Mail applications to:College of American Pathologists Foundation325 Waukegan RoadNorthfield, Illinois 60093-2750
ORBy Email: capfdn@cap.orgBy Fax: 847.832.8324Questions? 800.323.4040 x7324
Request for Applications for the American Cancer Society MEN2 Thyroid Cancer Consortium
The American Cancer Society announces this revised Request for Applications for the American Cancer Society MEN2 Thyroid Cancer Consortium. Up to seven (7) Research Scholar and/or Mentored Research Scholar grants and up to five (5) Postdoctoral Fellow grants will be awarded. The Consortium will be led by a single renowned senior scientist who will be awarded the American Cancer Society MEN2 Thyroid Cancer Professorship and act as leader for the overall program (details at links below). Appropriate areas of investigation include, but are not limited to: understanding consequences of RET mutations, molecular events underlying the development of MEN2-related tumors, improved animal models of MEN2, new screening and monitoring tools, new imaging approaches, and new pharmacologic and other strategies to blunt the effects of mutations in RET and other genes associated with medullary thyroid cancer.Individuals applying for a Research Scholar Grant must have an independent research or faculty position and can be at any stage of their career. These grants will be awarded for up to $200,000 a year, direct costs, for 5 years. Mentored Research Scholar Grants will be awarded to junior faculty members with a doctoral degree in a clinical or cancer control research discipline (e.g., M.D., and/or Ph.D.) that are within the first four years of a full time faculty appointment or equivalent, and have no more than 4 years of postdoctoral research experience immediately prior to their faculty appointment. The successful applicant is expected to transition into a career as an independent investigator. Awards are for up to five years and for up to $135,000 per year direct costs.Applicants for Postdoctoral Fellowships must have obtained their doctoral degree prior to activation of the fellowship. Awards are for three years with progressive stipends of $44,000, $46,000, and $48,000 per year, plus a $4,000 per year fellowship allowance. Individuals who have held a PhD or MD for more than 4 years at the time of application are not eligible.Deadline: Complete applications are due by April 1, 2010. Funding will begin January 1, 2011. For information regarding funding policies or to obtain an application, go to https://proposalcentral.altum.com or refer to the ACS website at www.cancer.org/research: select Funding Opportunities followed by Index of Grants, scroll down to Special Initiatives and select the appropriate RFA for MEN2 Thyroid Cancer.Charles Saxe, PhDScientific Program Director(404) 929-6919Charles.Saxe@cancer.org
Sontag Foundation Distinguished Scientist Awards--Brain Cancer
Inspire us. We're looking for early career scientists with the potential to create new waves across the brain cancer field. We're looking for increased survival rates and improved recovery for patients. We're looking for a cure or at the very least, treatments to make brain cancer a manageable chronic disease.In October 2010, The Sontag Foundation will present up to three Distinguished Scientist Awards to the most outstanding early career scientists with inspiring, potential-laden brain cancer research proposals. Each Award consists of a four-year funding component totaling a maximum of $600,000.Application deadline is March 24, 2010.Prior to contacting us, please read our FAQ.
http://www.sontagfoundation.org/grant_opps/grant_opps_dsa_faq.htm
Eligibility Requirements * Applicants must hold a doctoral degree in a biomedical science, medicine, or other health-related field. * At the time of application, applicants must hold their first independent full-time faculty appointment at the level of assistant professor, independent researcher or equivalent position at a tax-exempt 501(c)(3) academic, research or medical institution within the United States or an equivalent institution in Canada. If the institution grants tenure, the qualifying appointment must be on the tenure track. * Applicant's initial faculty appointment must have been made no earlier than March 1, 2007. * Applicant's career track and proposed research should demonstrate potential to generate new knowledge relating to causes, cure or treatment of primary brain tumors/brain cancer. * Research proposal submitted for funding must be a primary focus of applicant. * More than one individual from the same institution may apply for this award. * Reapplications in subsequent years of eligibility will be accepted by invitation only.FundingUp to $150,000 each of four years–as supported by budget request.Budgets must be approved in advance; funds will be disbursed to the institution in quarterly payments for up to four years, depending upon evidence of satisfactory progress. Progress reports must be received and approved prior to second, third and fourth year of funding. The Sontag Foundation will allow up to 15% of the award to support institutional overhead. Funding period will begin on or about October 1, 2010 and end on September 30, 2014.
Progress ReportingRecipients must submit a written progress report by September 1 during each of the first three years of the award. Report should include the following: * Two-page summary of scientific progress to date * Financial report detailing expenditures to date * Itemized budget for the next year of funding * Bibliography listing papers published or in press relating to Sontag project; include copies of published papers and accepted manuscripts * Short (less than one-page) update of research progress to date in layman's termsInformal progress reports are encouraged, and representatives of the Foundation may make periodic site visits at pre-arranged times.A final written report with copies of all publications relevant to awardee's research will be required within ninety days of completion of funding cycle. Final fiscal report will also be required at that time.
Terms of AwardAcknowledgment of support from The Sontag Foundation must be made when findings from sponsored research are reported or publicly given.Should the recipient wish to discontinue or substantially change the proposed project, leave the current institution or otherwise modify any terms of the award, he or she must seek approval of The Sontag Foundation in advance.Four-year support is contingent upon continued evidence of satisfactory progress.
Applying for the Award * For information to assist with preparation of your application, review the FAQ. Utilize application checklist as a guide to assure accurate submission of your application. * Full applications must be received in the Foundation office by noon on cut-off date. Facsimiles and e-mail submissions will not be considered. Guidelines found on application checklist must be followed. The original application plus six (6) print copies should be sent to:
The Sontag Foundation 816 A1A North, Suite 201 Ponte Vedra Beach, FL 32082
* E-mail notification will be sent to candidates upon receipt of application packet. * Selection procedures are designed to identify scientists who show the most outstanding promise of making fundamental/crucial contributions to new knowledge regarding primary brain tumors. In addition to scientific merit and the theme of the proposed research, consideration will also be given to the individual's past performance and promise as evidenced by the documentation submitted. * Applications will be evaluated by an independent Scientific Advisory Committee comprised of established scientists; The Sontag Foundation's internal selection committee will also evaluate applications. Applicants will be notified about the status of their proposals by August 1, 2010. * Finalists will be interviewed by a lay subcommittee during a pre-arranged site visit to their research institution. * Final selection of up to three applicants will be made by the selection committee and submitted for approval to the Board of Directors of The Sontag Foundation. * Number of awards (up to three) will be dependent upon receipt of applications of high scientific merit. * Final selection will be announced in October 2010.
1
